Hepatitis C virus infection in intravenous drug users

被引：17

作者：

Harder, J

Walter, E

Riecken, B

Ihling, C

Bauer, TM

机构：

[1] Univ Freiburg, Med Klin, Innere Med Abt 2, Dept Pathol, D-79106 Freiburg, Germany

[2] Univ Freiburg, Univ Hosp, Dept Med Gastroenterol Hepatol & Infect Dis 2, Freiburg, Germany

来源：

CLINICAL MICROBIOLOGY AND INFECTION | 2004年 / 10卷 / 08期

关键词：

drug users; hepatitis C; liver function tests; liver histology;

D O I：

10.1111/j.1469-0691.2004.00934.x

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Intravenous drug use (IVDU) remains a major means of hepatitis C virus (HCV) transmission. In this study, 101 drug users were studied prospectively after cessation of IVDU. Of these, 75.8% were anti-HCV positive, and 71.4% had elevated levels of alanine aminotransferase. These levels decreased significantly within 1 month of IVDU cessation (p 0.02). Liver biopsies showed minimal or mild fibrosis in 32 (71%) of 45 subjects, and severe fibrosis in two (4.4%) subjects. Anti-HCV-positive intravenous drug users in this study presented with mild liver disease and variable stages of disease progression. Biochemical disease activity might be affected by IVDU.

引用

页码：768 / 770

页数：3

共 50 条

[41] Prevalence, risk factors and genotypes of hepatitis C virus infection among drug users, Central-Western Brazil
Lopes, Carmen L. R.
Teles, Sheila A.
Espirito-Santo, Marcia P.
Lampe, Elisabete
Rodrigues, Fabiana P.
Motta-Castro, Ana Rita C.
Marinho, Thais A.
Reis, Nadia R.
Silva, Agabo M. C.
Martins, Regina M. B.
REVISTA DE SAUDE PUBLICA, 2009, 43
[42] Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin
Jonas, MM
Baron, MJ
Bresee, JS
Schneider, LC
PEDIATRICS, 1996, 98 (02) : 211 - 215
[43] Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment
Thorpe, LE
Ouellet, LJ
Hershow, R
Bailey, SL
Williams, IT
Williamson, J
Monterroso, ER
Garfein, RS
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 155 (07) : 645 - 653
[44] High prevalence of genotype 4 among hepatitis C virus-infected intravenous drug users in north-eastern Poland
Chlabicz, S.
Flisiak, R.
Kowalczuk, O.
Wiercinska-Drapalo, A.
Pytel-Krolczuk, B.
Prokopowicz, D.
Chyczewski, L.
JOURNAL OF MEDICAL VIROLOGY, 2008, 80 (04) : 615 - 618
[45] Hepatitis C virus infection
Fischler, Bjorn
SEMINARS IN FETAL & NEONATAL MEDICINE, 2007, 12 (03) : 168 - 173
[46] Hepatitis C related mortality in a cohort of drug users in Flanders
De Ryck, Henri
Mathei, Catharina
HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2020, 22 (03) : 5 - 11
[47] Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus - A 20-year prospective study
Smit, Colette
van den Berg, Charlotte
Geskus, Ronald
Berkhout, Ben
Coutinho, Roel
Prins, Maria
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 47 (02) : 221 - 225
[48] Molecular and epidemiological aspects of hepatitis C virus infection among crack cocaine users
Alves Del-Rios, Nativa Helena
de Araujo, Lyriane Apolinario
Bringel Martins, Regina Maria
Guimaraes, Rafael Alves
Dias de Matos, Marcia Alves
Amorim Caetano, Karlla Antonieta
Pinheiro, Raquel Silva
da Silva Franca, Divania Dias
da Silva, Leandro Nascimento
Teles, Sheila Araujo
dos Santos Carneiro, Megmar Aparecida
JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (08) : 1239 - 1245
[49] Risk of Hepatitis C virus re-infection following spontaneous viral clearance in injecting drug users: A systematic review
Corson, Stephen
Greenhalgh, David
Palmateer, Norah
Weir, Amanda
Hutchinson, Sharon
INTERNATIONAL JOURNAL OF DRUG POLICY, 2011, 22 (02) : 102 - 108
[50] Exploring the contingent reality of biomedicine: Injecting drug users, hepatitis C virus and risk
Carrier, N
Laplante, J
Bruneau, J
HEALTH RISK & SOCIETY, 2005, 7 (02) : 123 - 140

← 1 2 3 4 5 →